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Nance-Horan syndrome (NHS) is an X-linked developmental disorder characterized by congenital cataract,
dental anomalies, facial dysmorphism and, in some cases, mental retardation. Protein truncation mutations
in a novel gene (NHS) have been identified in patients with this syndrome. We previously mapped X-linked
congenital cataract (CXN) in one family to an interval on chromosome Xp22.13 which encompasses the
NHS locus; however, no mutations were identified in the NHS gene. In this study, we show that NHS and
X-linked cataract are allelic diseases. Two CXN families, which were negative for mutations in the NHS
gene, were further analysed using array comparative genomic hybridization. CXN was found to be caused
by novel copy number variations: a complex duplication–triplication re-arrangement and an intragenic del-
etion, predicted to result in altered transcriptional regulation of the NHS gene. Furthermore, we also describe
the clinical and molecular analysis of seven families diagnosed with NHS, identifying four novel protein trun-
cation mutations and a novel large deletion encompassing the majority of the NHS gene, all leading to no
functional protein. We therefore show that different mechanisms, aberrant transcription of the NHS gene
or no functional NHS protein, lead to different diseases. Our data highlight the importance of copy number
variation and non-recurrent re-arrangements leading to different severity of disease and describe the poten-
tial mechanisms involved.
INTRODUCTION
Nance-Horan syndrome (NHS) is an X-linked cataract–dental
syndrome (OMIM 302350) characterized by bilateral congeni-
tal cataract (usually requiring early surgery in affected males)
associated with microcornea and microphthalmia, multiple
dental anomalies and characteristic facial features
(1,2). Dental abnormalities include Hutchinsonian incisors
(screwdriver-shaped incisors), supernumerary maxillary inci-
sors and widely spaced teeth (diastema) (1–3). Associated
facial features include prominent nose and nasal bridge, long
face and large ears with anteverted pinnae. A proportion of
affected males (30% of cases) have developmental delay
(1–7). Carrier females typically display posterior Y-sutural
lens opacities often with cortical riders that are likely to be
congenital, whereas the dental and facial anomalies of the
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syndrome may be observed, but with a milder presentation (8).
The minimal locus for this syndrome was mapped on Xp22,
and subsequently mutations were identified within the
coding exons of a novel gene, NHS (9–12). The NHS gene
is alternatively spliced and composed of at least 10 coding
exons with at least 3 isoforms (Supplementary Material,
Fig. S1). Isoform A (NHS-A) has eight exons encoding a
1630-amino acid protein with an unusually large intron 1
(350 kb); isoform B (NHS-B) is transcribed from exon 1b
and translated from exon 4 encoding a 1335-amino acid
protein; and isoform C (NHS-C) is transcribed and translated
from exon 1a coding for a 1453-amino acid protein (11,13).
To date, 18 pathogenic mutations have been identified in 4
of the 10 coding exons of the NHS gene, all of which are pre-
dicted to result in a truncated NHS protein (11,12,14–18).
Isoform A is thought to be important in the pathogenesis of
NHS, because patient mutations identified in exon 1 are only
predicted to affect this isoform (11,12) (Supplementary
Material, Fig. S1). The function of the NHS protein is
unknown (13).
Non-syndromic X-linked congenital cataract is character-
ized by bilateral total nuclear cataract in affected males and
Y-sutural opacities in carrier females (19–22). Early studies
reported linkage with the Xg blood group on Xp22 (20). We
previously described a four-generation family with X-linked
congenital cataract (CXN) and mapped the disease locus to
an 3.5 Mb interval on Xp22.13 (23,24). This family did
not exhibit the dental phenotype and facial dysmorphology
of NHS; however, four of the six affected males also had con-
genital cardiac anomalies. The disease locus for this family
mapped to the same critical region as NHS, suggesting
allelic heterogeneity; however, mutation screening of the
NHS gene failed to identify the cause of disease (12,23,24).
The NHS critical interval is also syntenic with the mouse con-
genital cataract disease locus Xcat (X-linked cataract) (25,26).
The Xcat mutation is characterized by congenital total lens
opacities present at eye opening in both hemizygous males
and homozygous females, whereas in heterozygous carrier
females, the phenotype varies from barely noticeable to
totally opaque lenses, similar to the cataract phenotype of
NHS patients. The Xcat mouse was found to have a 487 kb
insertion in intron 1 of the mouse Nhs1 gene (27).
In this report, we describe a clinical and molecular analysis
of seven families diagnosed with NHS and two families with
X-linked cataract. All mutations causing an NHS phenotype
are null mutations predicted to produce no functional
protein. Our comparative genomic hybridization and sub-
sequent molecular analyses revealed novel copy number vari-
ations of the NHS gene leading to cataract, demonstrating for
the first time that NHS and X-linked cataract are allelic
diseases.
RESULTS
The majority of cases are described as classic NHS; however,
some clinical variability was observed in this patient group.
Pedigrees are shown in Figure 1 and a more detailed descrip-
tion of clinical findings is shown in Table 1.
NHS patients and mutations
Family A. Affected male II:1 had congenital nuclear lens opa-
cities and characteristic facial dysmorphism, and at age 4,
typical dental anomalies were seen (Table 1). The proband’s
mother, I:1, had similar facial features and bilateral fine
white dots in the posterior Y-sutures of her lenses, typical of
a carrier female lens (Fig. 2A). NHS gene screening revealed
a novel single-nucleotide substitution in exon 1, c.C472T,
which is predicted to result in a nonsense mutation at
p.Gln158X (Fig. 3). The introduction of a nonsense mutation
in exon 1 of the NHS gene is predicted to result in no
expression of the major isoform of NHS, isoform A.
Family B. Proband II:3 was diagnosed with bilateral congeni-
tal cataract and microphthalmia, typical dysmorphic features
and moderately delayed mental development (Table 1). He
had NHS dental anomalies including broad diastema
mediale, hyperplastic labial frenulum, screwdriver-shaped
incisors (Fig. 2B) and hypoplastic enamel (Fig. 2C). Sequen-
cing of the NHS gene in affected male (II:3) revealed a
novel frameshift mutation in exon 2. A deletion of 1 bp
(c.614delC) (Fig. 3) at the second position of codon 205
alters the reading frame and is predicted to result in a prema-
ture stop codon following the addition of 77 amino acid,
p.Pro206fsX282. Segregation analysis was performed to test
for carrier status in the proband’s asymptomatic mother (I:1)
and his sisters (II:1 and II:2, Fig. 1B). The mutation in
proband II:3 is considered to be a de novo mutation as it
was identified only in the affected male.
Family C. Two affected brothers (II:1 and II:2, Fig. 1C) were
diagnosed with NHS. Individual II:1 was diagnosed with
dense central cataracts and small corneas with characteristic
dental abnormalities (Fig. 2D). His older affected brother
(II:2) displayed similar ocular phenotype (Table 1). Their
mother (I:1) had typical carrier posterior Y-sutural opacities
(Fig. 2E) and undiagnosed impacted teeth. Screening of the
NHS gene revealed a nonsense mutation in exon 3. A C.T
transition (c.C742T) (Fig. 3) at the first position of codon
248 alters the amino acid sequence from an arginine to a
stop codon, p.Arg248X. The introduction of a nonsense
mutation in exon 3 of the NHS gene is predicted to result in
a severely truncated protein product. This mutation has been
previously reported (18).
Family D. Individual II:1 was diagnosed with bilateral micro-
phthalmia and congenital cataract as well as typical NHS
dental anomalies and facial dysmorphism (Table 1). He also
had mild bilateral hearing loss, and computed tomography
(CT) scans demonstrated inner-ear dysplasia. His mother
(I:1) had a history of cataracts diagnosed in her 20s and
dental extraction of multiple supernumerary teeth. Interest-
ingly, we detected a C.T nonsense mutation (c.C742T,
p.Arg248X) in proband II:1 (Fig. 3) and his carrier mother
I:1, which was identical to the nonsense mutation we identified
in Family C and to a previously described mutation (18).
Family E. This family consists of three affected males (II:1,
III:2 and III:3) and two females of unknown status (II:2 and
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III:1) (Fig. 1E). The proband, individual III:2, had bilateral
congenital cataract and typical NHS dysmorphic features
and dental anomalies, including screwdriver-shaped incisors
(Fig. 2F). He was also diagnosed with finger and toe clinodac-
tyly and behavioural problems. His affected brother (III:3) was
diagnosed with bilateral cataract at age 2 and had a similar
facial, dental and behavioural phenotype (Table 1). Their
affected uncle (II:1) also had typical features of NHS. Screen-
ing of the NHS gene in the affected male (III:2) revealed a
novel frameshift mutation in exon 6. A deletion of 4 bp
(c.2550–2553delAGAA) (Fig. 3) at the third position of
codon 850 alters the reading frame and is predicted to result
in a premature stop codon following the addition of 3 amino
acid, p.Lys850fsX852. The proband’s mother (II:2) and
sister (III:1) were both heterozygous for this sequence change.
Family F. Individual II:1 was diagnosed with dental
anomalies, dysmorphic facial features and developmental
delay, but with an unusually mild cataract for NHS (Fig. 2G
and Table 1). His mother (I:1) had typical carrier features of
NHS with asymptomatic cataract of very fine dots in a pos-
terior Y-shaped distribution. Her teeth were also anomalous
with poor enamel.
All coding exons of the NHS gene were successfully ampli-
fied and sequenced, except for exon 8. To understand why it
was not possible to amplify exon 8, a chromosome walking
strategy was adopted. Three exon 8 specific primers were
designed: NHSEx8ext, NHSEx8 and NHSEx8a (Supplemen-
tary Material, Table S1). Using primer pair NHSEx8a/Uni, a
unique fragment of 700 bp was amplified. The PCR
product was gel-purified and sequenced to reveal an insertion
at the first position of codon 1521 (c.4561) (Fig. 3). Bioinfor-
matic analysis of the sequence from patient II:1 revealed a
genomic re-arrangement which affects the majority of NHS
exon 8 coding sequence and the 30-UTR. The NHS gene is
truncated within exon 8 at position c.4561, and the deleted
region extends another 4.3 kb to include sequence upstream
of the neighbouring SCML1 gene. The breakpoint junction
also contains an insertion of a 17 bp fragment from the oppo-
site (2) strand (Fig. 4A). Thus, a novel mutation in exon 8
was detected, which is the first NHS chromosomal
re-arrangement described and is predicted to result in a prema-
ture stop codon with the addition of 11 aberrant amino acid,
p.Ser1521fsX1531 (Fig. 3). A diagnostic PCR reaction was
designed, using primer pair NHSEx8CR (Supplementary
Material, Table S1), which successfully confirmed the pres-
ence of the chromosome re-arrangement in patient II:1 and
its absence from 200 controls. Sequence analysis of the junc-
tion fragment revealed features similar to a previously
described genomic re-arrangement in LIS1 (28), suggesting
that this complex re-arrangement may be caused by a recently
described mechanism of replication named fork stalling and
template switching (FoSTeS) (29).
Family G. Affected male II:1 had bilateral congenital cataract,
microphthalmia, dental anomalies, dysmorphism and develop-
mental delay (Fig. 2H and Table 1). In addition to the typical
features of NHS, individual II:1 was reportedly a ‘floppy baby’
and remained hypotonic. NHS gene exons failed to amplify in
patient II:1 DNA. The patient DNA sample integrity was
further tested with other primer pairs elsewhere on the X-
chromosome, which amplified successfully. NHS exon 1 was
Figure 1. Pedigree structures. Families A, B, C, D, E, F and G were diagnosed with NHS. Families H and I were diagnosed with X-linked cataract. Black boxes
denote affected males; dotted circles, carrier females; clear boxes and circles, unaffected individuals; and clear circles with a question mark, females with
unknown clinical status.
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Table 1. Clinical features of individuals from study families
Family
ID
Individual Ophthalmological Dental Developmental
delay and
behavioural
problems
Dysmorphism Other
A I:1 Bilateral fine white dots in the
Y-suture of the lenses
Cortical wedge opacities
Optic discs with large
cup-to-disc ratio (0.8
bilaterally)
No evidence of glaucoma
— — Large ears and
anteverted
pinnae
—
II:1 Bilateral small corneas (8.5 mm
diameter)
Irides lacking crypts
Congenital white Y-sutural lens
opacities
Nuclear lens opacities with
diffuse edge and clear
peripheral lens
Lensectomy was performed
within the first month
Both optic discs have large cups
(0.6 right, 0.5 left)
No evidence of glaucoma
Typical anomalies were
seen at age of 4
— Large ears and
anteverted
pinnae at 1
month
—
B II:3 Bilateral congenital dense
cataract
Microphthalmia
Extracapsular cataract
extraction to clear pupil area
and anterior vitrectomy was
performed at 7 weeks of age
and high plus contact lenses
were fitted simultaneously
Secondary glaucoma
Diastema mediale
Hyperplastic labial
frenulum
Screwdriver-shaped
incisors
Hypoplastic enamel
Moderately
delayed mental
development
Impaired social
skills
Not able to write or
draw at age 8
Long thin face
Large protruding
ears
Delayed motor development
C I:1 Posterior Y-sutural opacities Undiagnosed impacted
teeth
No — —
II:1 Dense central cataracts
Small corneas (horizontal
corneal diameter 8.5 mm) at
12 days
Underwent bilateral lensectomy
at 2.5 weeks and wore contact
lenses from 4 weeks
Characteristic dental
abnormalities
No Prominent ears —
II:2 Congenital cataracts
Small corneas
Bilateral posterior lenticonus
Aphakic glaucoma and suffered
an expulsive haemorrhage at
trabeculectomy surgery
Nystagmus
— No — —
D I:1 Cataracts diagnosed in her 20s Dental extraction of
multiple
supernumerary teeth
No — —
II:1 Bilateral microphthalmia,
Congenital cataract,
Ptosis
Secondary glaucoma.
Peg-shaped teeth
Supernumerary incisors
No Facial
dysmorphism
Bilateral hearing loss
CT scans demonstrated
inner-ear dysplasia.
E II:1 Bilateral congenital cataract. Typical dental
anomalies
Developmental
delay
— —
III:2 Bilateral congenital cataract. Screwdriver-shaped
incisors
Behavioural
problems
Facial
dysmorphism
Finger and toe clinodactyly
III:3 Bilateral cataract at age 2 Typical dental
anomalies
Behavioural
problems
Facial
dysmorphism
—
Continued
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present, but all other NHS exons were deleted in this patient,
which is predicted to result in no protein product (Fig. 3C).
PCR analysis of the genes downstream of the NHS gene,
SCML1, RAI2, CXorf20 and SCML2, revealed an extensive
segmental deletion of 0.9 Mb. The deleted region encom-
passes the majority of the NHS gene (exons 2–8), SCML1,
RAI2 and CXorf20 (Fig. 3C). The SCML2 gene is not
deleted in this patient (Fig. 3C).
Complex duplication–triplication event at the NHS locus
and resulting phenotype
The phenotype for Family H has been previously reported as
X-linked cataract (CXN) without the features of NHS (19).
In brief, all affected males required cataract extraction in the
first few months of life. Carrier females had mild fan-shaped
central nuclear opacities (19). Features typical of NHS such
Table 1. Continued
Family
ID
Individual Ophthalmological Dental Developmental
delay and
behavioural
problems
Dysmorphism Other
F I:1 Asymptomatic cataract of very
fine dots in a posterior
Y-shaped distribution
Large cupped optic discs
without glaucoma
Anomalous teeth with
poor enamel
— — —
II:1 Eye test failed at 7 years 8
months with an acuity of
LogMAR 0.3 right, 0.26 left
Unusually mild cataract
At age 11, his corneas were
slightly small, 10.5 mm
Bilateral inferior wedge
opacities in the lens cortex
and fine nuclear dot opacities
Typical dental
anomalies
Developmental
delay and
behavioural
problems
Facial
dysmorphism
—
G II:1 Bilateral congenital cataract
Microphthalmia
A magnetic resonance imaging
scan showed small anterior
visual pathways and a general
lack of bulk of white matter.
Typical dental
anomalies
Developmental
delay
Facial
dysmorphism
Hypotonic
H All males Required cataract extraction in
the first few months of life
No No No Four out of six affected males
were diagnosed with
congenital heart defects
(ductus arteriosus, tetralogy
of Fallot, ventriculoseptal
defect and stenosis of a
major cardiac vessel)
All females Mild fan-shaped central nuclear
opacities
No No No —
I II:1 Y-sutural lens opacities
Her father had had cataract
surgery at 45 years of age
No No No —
III:1 Dense bilateral nuclear cataracts
at 6 weeks.
Lensectomy was performed at
12 weeks and a posterior
lenticonus found of the right
lens.
Both eyes had normal corneal
diameter of 11 mm, axial
lengths 18 mm right,
17.9 mm left, and no
evidence of glaucoma.
At 6 years of age, his acuity was
0.52 logMAR right and 1.3
LogMAR left with dense left
amblyopia and no evidence
of glaucoma
No No No Laryngomalacia
(inspiratory stridor)
Pre-auricular pit
III:2 Mild posterior sutural lens
opacities, not operated on
No No No Laryngomalacia
(inspiratory stridor)
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as dental anomalies, dysmorphism and developmental delay
were not described in this family; however, congenital heart
defects with a variety of diagnoses (ductus arteriosus, tetral-
ogy of Fallot, ventriculoseptal defect and stenosis of a major
cardiac vessel) were reported in four out of six affected
males at the time of clinical examination. Genetic linkage
studies in this family had previously shown that CXN was
linked to the NHS locus (19,20). All coding exons of the
NHS gene were successfully amplified and sequenced and no
mutations were identified (12). Here, we describe the analysis
of DNA from an affected male (IV:4) for copy number vari-
ation using a dense X-chromosome array.
Comparative genomic hybridization array data analysis
revealed the presence of a complex re-arrangement consisting
of triplication of a region encompassing NHS, SCML1 and
RAI2 genes embedded within a duplicated region (Fig. 5A).
The mean log2 ratio indicates that an 0.5 Mb region
between ChX:17334242 and ChX:17800551 is triplicated,
flanked by a duplication that extends 0.2 Mb distal and
0.1 Mb proximal to the identified triplication (Fig. 5A). To
validate the presence of a triplicated region, a SYBR-green
quantitative real-time PCR (qPCR) experiment was performed
on four family samples: DNA from affected males IV:1 and
IV:4 and DNA from unaffected males III:2 and V:3. Using
primer pair NHSEx8c (Table S1) located within the triplicated
region, the number of amplified copies of DNA for the
affected males reaches the fluorescence threshold with a
smaller CT value compared with the number of amplified
copies of DNA for the unaffected males. The results obtained
from Data Analysis for Real-Time PCR (DART-PCR) are
shown in Figure 5B, and the Ro values averaged for controls
and patients show a significant increase of 2.8-fold in the
two affected males compared with the two unaffected males.
The triplicated region includes the NHS gene lacking exon
1, and the entire SCML1 and RAI2 genes. To define the break-
point regions of this complex re-arrangement, a chromosome
walking strategy was used. Three target-specific primers
(TSPs) were designed in the breakpoint 3 region (Fig. 5A):
Bk3F1, Bk3F2 and Bk3F3 (Supplementary Material,
Table S1). Using primer pair Bk3F3/Uni, amplification of
two products was detected. Direct sequencing of these pro-
ducts revealed that breakpoint 3 (at ChrX:17800261) joins
sequence downstream of RAI2 to sequence of unknown
origin (Fig. 5C). The same strategy was used to define the
proximal breakpoint (breakpoint 4, Fig. 5A). Additional
TSPs, Bk4F1, Bk4F2 and Bk4F3 (Supplementary Material,
Table S1), were designed in the proximal breakpoint region
(breakpoint 4). Amplification of an 1.4 kb product was
detected using primer pair Bk4F3/Uni. Direct sequencing of
this product revealed that breakpoint 4 (at ChrX:17926944)
joins sequence downstream of the RAI2 gene to sequence
upstream of exon 1 of the NHS gene (ChrX:17105038)
(Fig. 5C). Attempts to walk across distal breakpoint 2
located between ChrX:17104696 and ChrX:17105121 were
not successful, and walking across distal breakpoint 1
located between ChrX:17334022 and ChrX:17334242 was
not performed.
Sequence analysis of breakpoint 4 also revealed the pres-
ence of ‘mirrored’ sequences at both the distal and proximal
re-arrangement boundaries (Fig. 4B). This breakpoint occurs
in sequence which is conserved across species (Fig. 4D) and
is possibly a promoter region for the NHS gene. Disruption
of this conserved upstream region is predicted to affect the
transcription of one copy of the NHS gene. Therefore, we con-
clude that one copy of the NHS gene lacks exon 1 (Fig. 5A),
another copy has all known exons but is disrupted upstream,
and a third copy is intact. The three copies of the SCML1
and RAI2 genes appear complete. The additional phenotype
of congenital heart defects observed in some affected males
could be due to perturbed NHS gene transcription or increased
dosage of the NHS, SCML1 or RAI2 genes. Segregation of the
complex copy number variation in Family H was confirmed
using primer pair CXN–Bk (Supplementary Material,
Table S1) designed to amplify across breakpoint 4 of the seg-
mental duplication–triplication (Fig. 5D). A PCR product of
338 bp representing successful amplification across the break-
point was detected in all 10 affected and carrier individuals
and not in unaffected members of Family H.
Figure 2. Patient phenotypes. (A) Carrier cataract phenotype (I:1) of Family A. (B) Family B dental phenotype (II:3) showing screwdriver-shaped incisors and
broad diastema mediale with hyperplastic frenulum mediale and (C) hypoplastic enamel. (D) Family C proband (II:1) with dental anomalies and (E) sutural
cataract phenotype of carrier mother (I:1). (F) Family E proband (III:2) with screwdriver-shaped incisors. (G) Relatively mild cataract phenotype of affected
male (II:1) in Family F. (H) Typical features of NHS in affected male II:1 from Family G.
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NHS intragenic deletion and resulting phenotype
Individual III:1 from Family I was diagnosed with dense bilat-
eral nuclear cataracts at 6 weeks. At 2 months, there appeared
to be no dysmorphic features characteristic of NHS. However,
he did have a small pit in the right external ear in the ascend-
ing limb of the helix, which may be a small pre-auricular
sinus. His older brother, individual III:2, shows no NHS fea-
tures or pre-auricular sinus and had milder posterior sutural
lens opacities, which were not operated on. Their mother
(II:1) showed typical carrier Y-sutural lens opacities. Her
father had cataract surgery at 45 years of age. There were
no further details available of this individual. This family
was therefore diagnosed as X-linked cataract. Laryngomalacia
was also noted, which presented as inspiratory stridor in both
boys. All of the NHS gene-coding exons and their splice sites
were successfully amplified and sequenced. No mutation was
identified in this family.
We then analysed DNA from individual III:1 for copy
number variation using a dense X-chromosome array as
described. Comparative genomic hybridization array data
revealed the presence of an intragenic segmental deletion
(Fig. 5E). The mean log2 ratio indicates that an 5.1 kb
region, between ChrX:17461256 and ChrX:17466720 located
within the NHS gene, is deleted. Using primers pair NHSin-
tron1 (Supplementary Material, Table S1), PCR amplification
Figure 3. Patient mutations identified in the NHS gene. (A) Schematic representation of the X-chromosomal region surrounding the NHS gene (16.80–
18.30 Mb). Arrows in red indicate position and direction of genes. Genomic structure of the NHS gene is shown with mutations identified to date. (B) Sequence
chromatograms showing protein truncation mutations identified in Families A–F. Mutations detected in affected male sequence are shown below the unaffected
control male chromatograms. (C) Agarose gels showing amplification of NHS exon 1a and SCML2 exons 1 and 14 and absence of NHS exon 8, SCML1 exons 1
and 8, RAI2 exon 3, CXorf20 exons 1 and 14 for the affected male in NHS Family G (II:1) compared with a control male (þ). Corresponding amplicon sizes are
indicated.
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of this region in the affected male (III:1) produced a smaller
DNA fragment of 913 bp compared with a product of
5724 bp in an unaffected control sample (Fig. 5F). Sequence
analysis revealed a 4.8 kb deletion within the large
(350 kb) intron 1 of the NHS gene (Fig. 5G). Analysis of
the junctional sequence showed microhomology between the
distal and proximal breakpoints, with 2 bp (CT) of perfect iden-
tity (Fig. 4C). The mechanism for this deletion could be either
non-homologous end-joining (NHEJ) or a single FoSTes event.
The intragenic region between ChrX:17465805 and
ChrX:17466048 contains several highly conserved regions.
The largest conserved region within the deletion is shown in
Figure 4E and may be a regulatory sequence for the NHS
gene. This deletion is therefore predicted to cause altered tran-
scriptional regulation of the NHS gene.
DISCUSSION
In this study, we have identified several novel mutations in the
NHS gene that cause NHS (Table 2). Importantly, we have
also identified copy number variation of NHS in two families
with X-linked cataract but without other features of NHS,
revealing for the first time that NHS and X-linked
cataract are allelic (Table 2). We suggest that lack of functional
NHS protein causes NHS, whereas aberrant transcription of the
NHS gene leads to a milder X-linked cataract phenotype.
We identified copy number variations of the NHS gene in
two families with X-linked cataract, using array comparative
genomic analysis (CGH). A segmental duplication–tripli-
cation encompassing the NHS, SCML1 and RAI2 genes
(0.8 Mb) was identified in Family H, and a 4.8 kb deletion
in NHS intron 1 was identified in Family I. This is the first
report describing X-linked cataract phenotypes caused by
copy number variation mutation. There is a striking difference
in predicted mutational consequence leading to cataract or
syndrome. NHS is caused by null mutations leading to non-
functional NHS protein. X-linked cataract in the families
described is likely to be caused by aberrant transcription of
the NHS gene. This hypothesis is supported by our molecular
analyses of two cataract families described in this study and
also by the identification of the mutation causing X-linked cat-
aract (Xcat) in a mouse model (27).
Figure 4. Sequence analysis of chromosome re-arrangements. Sequence analysis of breakpoint junctions of chromosome re-arrangements in Families F, H and I,
and conserved regions in Families H and I. Normal distal genomic sequence is shown in orange on the top line; patient genomic breakpoint sequence is shown on
the middle line; normal proximal genomic sequence is shown in blue on the bottom line. Chromosome positions are indicated along the sequences. (A) Chro-
mosomal re-arrangement in Family F. A 17 bp fragment (green) between the distal and the proximal reference sequence is derived from the reverse strand in the
intergenic region between NHS and SCML1 genes. Regions of homology at the distal and proximal breakpoint sequences are boxed. (B) Breakpoint 4 of the
complex duplication–triplication copy number variation in Family H. An insertion of 8 bp at the distal breakpoint (green) and an 18 bp deletion at the proximal
breakpoint (blue dash) were detected. ‘Mirrored’ sequences at the distal and proximal breakpoint regions are boxed. (C) Deletion breakpoint in Family I shows
identical nucleotides between the proximal and distal flanking sequence. A region of complete homology is boxed. (D) Breakpoint 4 in Family H occurs within a
240 bp sequence conserved across species. (E) Sequence conservation across species of a 340 bp region within the deletion in Family I.
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In CXN Family H, the segmental duplication–triplication
breakpoint 4 occurs in a region located upstream of one
copy of the NHS gene. This region is conserved across
species (Fig. 4D). It is therefore likely that this region harbours
important promoter sequence elements required for the spatial
and temporal expression of NHS during development, and that
disruption of the promoter leads to aberrant transcription of
one copy of the NHS gene in the affected members of this
family. Another copy of the NHS gene lacks exon 1; therefore,
isoform A will not be expressed (Fig. 5A). The third copy of
the NHS gene in affected members of this family may have
preserved developmental expression control elements,
however increased dosage of the transcript could also be a
mechanism leading to CXN in affected members of the family.
In CXN Family I, a 4.8 kb deletion was detected within
the unusually large intron 1 (350 kb) of the NHS gene.
Figure 5. Copy number variations identified in CXN families. (A) Array CGH results from patient IV:4 in Family H. A complex duplication–triplication was
found between ChX:17105121 and ChX:17926943. Position of the NHS gene and neighbouring genes are shown, and affected genes are highlighted in red.
Genes present at normal copy number are shown in green. A schematic representation of the duplication–triplication region is shown below depicting breakpoint
regions 1–4. (B) Relative quantification of qPCR data showing Ro values averaged between affected samples IV:1 and IV:4 normalized to Ro values averaged
between WT samples III:2 and V:3. (C) Sequence derived from breakpoint 3 is shown with ChrX:17800261 joined to sequence of unknown origin, and sequence
derived from breakpoint 4 is shown with ChrX:17926944 sequence joined to ChrX:17105038 sequence. (D) Genetic analysis of other relatives in the family
demonstrated segregation of this complex re-arrangement in Family H with all affected and carriers individuals. (E) Array CGH results from patient III:1 in
Family I. A deletion of a 4.8 kb region is located between ChrX:17461256 and ChrX:17466720. This deleted region is located within intron 1 of the NHS
gene and is shown in red above the CGH data. (F) Agarose gel showing that PCR across the deletion breakpoint in affected male III:1 (CXN Family I) produces
a 913 bp fragment compared with a control (þ) fragment of 5724 bp. Fragment sizes are indicated. (G) Patient chromatogram showing the breakpoint sequence,
which occurs at ChrX:17461765.
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Interestingly, this deleted region also contains conserved
sequences, which may represent potential promoter sequences,
such that the deletion could lead to aberrant transcription of the
NHS gene. This is supported by the fact that in the compact
genome of Fugu, where gene density is high and introns are
small (majority ,150 bp) (30), the large NHS intron 1 is pro-
portionally retained (30 kb), suggesting the presence of func-
tional elements. The hypothesis that intron 1 is important for
transcriptional regulation is supported by the identification of
the mutation in the Xcat mouse (27). The large size of NHS
intron 1 is conserved in mouse (283 kb) and the Xcat mouse
has a 487 kb insertional mutation in Nhs intron 1, resulting in
a 770 kb separation of exons 1 and 2 (27). This led to the
absence of expression of the major isoform of the Nhs gene
which contains exon 1 (isoform A) (27). Collectively, the
Xcat mouse mutation and phenotype, and our data indicating
aberrant transcription of the NHS gene causes CXN, suggest
that the Xcat mouse is an excellent model for CXN, but may
not be a model for NHS. A knock-in mouse mutant of an
NHS patient protein truncation mutation, or knock-out model,
may lead to a dental phenotype, developmental delay and
perhaps other symptoms associated with NHS.
Congenital heart defects were observed in four of six
affected males in Family H (23). The additional phenotype
in this family could be due to aberrant transcription of the
NHS gene or increased dosage (triplicated) of the NHS,
SCML1 or RAI2 genes. Retinoic acid-induced 2 protein
(encoded by RAI2) is a good candidate, as retinoic acid is
important for heart development (31). Developmental
expression studies in mouse suggest that Nhs may also play
a role in heart development (11). The mutation identified in
NHS Family G supports the hypothesis that aberrant transcrip-
tion of the NHS gene is responsible for congenital heart
defects in CXN Family H. In Family G, we detected a segmen-
tal deletion which encompasses the majority of the NHS gene
and the entire SCML1, RAI2 and CXorf20 genes. Despite the
absence of these additional genes (SCML1, RAI2 and
CXorf20), Family G did not exhibit any cardiac abnormalities.
It would appear therefore that aberrant transcription or a
dosage effect of NHS leads to cardiac anomalies in Family
H. Further support comes from a recent report describing a
2.8 Mb microdeletion of 16 genes on Xp22, including NHS
and RAI2, with a phenotype of early seizures, severe encepha-
lopathy, NHS and the congenital heart defect, tetralogy of
Fallot (32). However, further work is required before one
can assign heart defects in patients with specific genes affected
by copy number variations on Xp22.
The intragenic re-arrangement detected in NHS exon 8 in
Family F, segmental duplication–triplication in Family H
and segmental deletion in Family I are non-recurrent
genomic re-arrangements. We performed molecular analysis
of breakpoints to determine the nature and mechanism of
these genomic re-arrangements. In Family F, the chromosomal
re-arrangement is likely to have occurred by the newly
described mechanism of replication FoSTeS, as microhomol-
ogy was detected at the junction breakpoints (29). In Family
I, the segmental deletion occurred either by NHEJ or by a
single FoSTeS event, as microhomology was also noted at
the breakpoint junction; however, a precise mechanism
could not be assigned. The duplication–triplication break-
points 3 and 4 confirm two independent events leading to
the complex re-arrangement observed with CGH in Family
H. Breakpoint 4 appears to be caused by a new mechanism,
as ‘mirrored’ sequences were identified at the junctional frag-
ments. To our knowledge, the breakpoint sequence of only one
other segmental duplication–triplication has been previously
reported (28). In this article, the chromosomal re-arrangement
encompasses a region on 17p13 in one patient with a develop-
mental brain abnormality, but no mirrored sequences at the
breakpoints were identified (28). We suggest, therefore, that
novel mechanisms may be responsible for the re-arrangements
identified in Families H and I which warrant further
characterization.
Four novel protein truncation mutations, p.Q158X (exon 1),
p.P206fs (exon 2), p.K850fs (exon 6), p.S1521fs (exon8), and
a large deletion encompassing the majority of the NHS gene
were identified in five of the seven NHS families. The two
remaining NHS families, one from the UK (Family C) and
one from Canada (Family D), were found to have the same
protein truncation mutation p.R248X (exon 3). This mutation
has also been identified in an Australian NHS family (18).
Since the majority of NHS families described have a unique
mutation, it is likely that these families are related. Referring
clinicians confirmed that Families C and D are likely to be
related, however their relationship with the Australian family
previously described has not been confirmed. We have
also identified a de novo mutation in exon 2 (p.P206fs) in
one NHS patient and the first intragenic chromosomal
re-arrangement causing NHS, which results in a frameshift
mutation in exon 8 (S1521fs), predicted to result in a trun-
cated, aberrant protein product. In addition, we identified a
large deletion encompassing the majority of the NHS gene
in Family G predicted to result in no NHS protein. This
brings the total number of mutations identified in the NHS
gene causing NHS to 23, all of which are null mutations
(11,12,14–18). A summary of the clinical findings for each
family is given in Table 1. All patients with null mutations
Table 2. Summary of mutations in the NHS gene
Family
ID
NHS gene mutation and exon Predicted consequence
A c.C472T
Exon 1
p.Gln158X
Protein truncation
B c.614delC
Exon 2
p.Pro206fsX282
Protein truncation
C c.C742T
Exon 3
p.Arg248X
Protein truncation
D c.C742T
Exon 3
p.Arg248X
Protein truncation
E c.2550-2553del4bp
Exon 6
p.Lys850fsX852
Protein truncation
F c.4561
Intragenic genomic re-arrangement
in exon 8
p.Ser1521fsX1531
Protein truncation
G Deletion of NHS gene downstream
of exon 1
No protein product
H Segmental duplication–triplication Altered transcriptional
regulation
I Intragenic segmental deletion
within intron 1
Altered transcriptional
regulation
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have the classic cataract and dental anomalies, which charac-
terize NHS (1,2). Clinical variability also exists in our patient
group. Given that Families C and D have the same mutation,
one might expect clinical correlation; however, individual
II:1 in Family D had bilateral mild hearing loss, with CT
scans showing inner-ear dysplasia. This is the first report of
an auditory phenotype associated with NHS. We found that
UniGene cluster Hs.201623 has several NHS cDNA clones
derived from fetal cochlea, suggesting that the gene may be
important for the development of this organ. However, the
fact that neither of the two affected boys in Family C suffers
from hearing loss suggests that other genetic or environmental
factors influence the phenotype. In our NHS patient cohort,
developmental delay and behavioural problems were com-
monly observed (four out of seven NHS families, 57%),
which we propose is also due to modifier effects influencing
phenotype. Interestingly, no missense mutations in the NHS
gene have been reported to date, which suggests that missense
mutations do not cause disease, or that they lead to a more
severe phenotype. Other loci and genes causing syndromic
or isolated X-linked cataract have been described, for
example Lowe syndrome on Xq26.1 and a locus on Xq24
(33,34). Further investigation of phenotypic variation and
CNVs at these loci will enhance our understanding of pheno-
type–genotype correlation.
We have demonstrated that NHS and CXN are allelic dis-
orders caused by different effects on NHS gene function and
expression. Our data show the importance of copy number
variation and non-recurrent re-arrangements leading to differ-
ent severities of disease and describe the potential mechanisms
involved. We have also shown that genetic or environmental
modifiers of NHS gene function influence phenotype. Our
study, taken together with the Xcat mouse study, indicates
that the unusually large intron 1 of the NHS is important for
gene regulation, and that the Xcat mouse is a model for
X-linked cataract.
MATERIALS AND METHODS
Patients and clinical assessment
Patients diagnosed with NHS, or CXN, were ascertained in
clinics in the UK, Canada and Norway. Informed consent
was obtained from all individuals or their guardians and a
blood sample taken for genomic DNA isolation. Where avail-
able, DNA from additional family members was collected.
Family members were examined by clinical geneticists and/
or ophthalmologists and family histories were taken. Of the
nine families described (A–H), seven were diagnosed with
NHS and two with CXN. Pedigree structures are shown in
Figure 1. Pedigree H is an abridged pedigree of a previously
described family (23,24), and part of Family C was previously
described (11; Pedigree 6). All were consistent with X-linked
inheritance and lacked a molecular diagnosis, however reces-
sive inheritance could not be ruled out for Families B and E.
NHS gene screening
All NHS coding exons and their splice sites were amplified and
sequenced directly from genomic DNA (see Supplementary
Material, Table S2, for primers and conditions). ReddyMixTM
PCR Master Mix (Abgene, Epsom, UK) was used for amplifi-
cation with 2 pmol of each primer and 150 ng DNA. For NHS
exon 1, Abgene Extensor Hi-Fidelity PCR Master Mix was
used. PCR conditions were as follows: 958C for 5 min, fol-
lowed by 30 cycles at 958C for 30 s, annealing temperature
Tm (Supplementary Material, Table S2) for 30 s, and 728C
for 30–90 s, with a final extension at 728C for 5 min. PCR
products were purified using ExoSAP- ITw (USB), following
manufacturer’s protocols. Purified PCR products were
sequenced using ABI BigDye terminator cycle sequencing
chemistry version 3.1 on a 3730 DNA Analyzer (Applied Bio-
system) following manufacturer’s protocols. Patient DNA
sequences were analysed using Lasergene software
(DNASTAR Inc.). To verify the pathogenicity of the
mutations identified, 200 control male DNA samples (i.e.
200 X-chromosomes) were tested. Specific primer pairs, incor-
porating the mutation detected, were designed to test control
individuals (Supplementary Material, Table S1).
Comparative genomic hybridization
Array CGH was used to evaluate DNA copy number differ-
ences on the X-chromosome (performed by NimbleGen
Systems Inc.). Male patient DNA was labelled with Cy-3,
and a reference male DNA sample was labelled with Cy5.
Affected individual IV:4 from CXN Family H and affected
individual III:2 from CXN Family I were hybridized indepen-
dently to a dense X-chromosome array with a median probe
spacing of 340 bp. The data were visualized using SignalMap
software (NimbleGen System Inc.). Array construction, label-
ling, hybridization, normalization and data analysis were per-
formed at NimbleGen, and subsequent data analysis was
performed in-house.
Chromosome walking
The isolation and characterization of unknown DNA sequence
adjacent to known sequence were necessary for Families F and
H. A Seegene DNA Walking SpeedUpTM Premix Kit
(Biogene, UK) was used for genome walking following man-
ufacturer’s protocols. TSPs 1, 2 and 3 (Supplementary
Material, Table S2) were designed to be used with DNA-
walking ACP primer and Universal primer for primary,
secondary and tertiary genome-walking amplification. The
resulting tertiary PCR products were gel-separated, purified
(QIAquick Gel Extraction Kit, Qiagen) and sequenced. Break-
point sequences were analysed by comparison with reference
sequences using tools available at UCSC and Ensembl
genome browsers.
SYBR-Green qPCR assay
qPCR was performed using Power SYBR Green Mastermix
(Applied Biosystems) on an Applied Biosystems 7900 HT
Fast Real-Time PCR System. Each reaction was run in tripli-
cate and contained 2 power SYBR Green master mix,
2 pmol of each primer and 100 ng DNA in a final reaction
volume of 25 ml. Cycling conditions were as follows: 958C
for 10 min to activate the Amplitaq Gold polymerase, fol-
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lowed by 40 cycles at 958C for 15 s (denaturation) and 608C
for 1 min (annealing and extension). Dissociation curves
were then generated by heat denaturation over a temperature
gradient from 60–958C to ensure no primer-dimers had
formed and to check for a single amplicon. To verify the pres-
ence of a single PCR product, samples were also electrophor-
esed on a 2% agarose gel.
Data analysis
Data were obtained using SDS sequence detector 2.2.2 soft-
ware (Applied Biosystems). Raw data exported from SDS
2.2.2 were analysed using DART-PCR (35). This workbook
automatically calculates threshold cycles, amplification effi-
ciency and resulting Ro values with the associated error.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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